BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 7453783)

  • 21. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis].
    Germin Petrović D
    Acta Med Croatica; 2004; 58(1):31-6. PubMed ID: 15125391
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complement and dengue haemorrhagic fever/shock syndrome.
    Malasit P
    Southeast Asian J Trop Med Public Health; 1987 Sep; 18(3):316-20. PubMed ID: 3501613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser.
    Gardner BP; Pleyer U; Mondino BJ; Sumner HL; Frieberg ML; Imperia PS
    Ophthalmic Surg Lasers; 1995; 26(6):568-71. PubMed ID: 8746579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxygen free radical generation during cardiopulmonary bypass: correlation with complement activation.
    Cavarocchi NC; England MD; Schaff HV; Russo P; Orszulak TA; Schnell WA; O'Brien JF; Pluth JR
    Circulation; 1986 Nov; 74(5 Pt 2):III130-3. PubMed ID: 3769186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deleterious effects of cardiopulmonary bypass. A prospective study of bubble versus membrane oxygenation.
    van Oeveren W; Kazatchkine MD; Descamps-Latscha B; Maillet F; Fischer E; Carpentier A; Wildevuur CR
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):888-99. PubMed ID: 3158783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complement and the damaging effects of cardiopulmonary bypass.
    Westaby S
    Thorax; 1983 May; 38(5):321-5. PubMed ID: 6603674
    [No Abstract]   [Full Text] [Related]  

  • 28. [Activation of complement and serial changes of anaphylatoxin (C3a, C5a) in patients for open-heart surgery using a membrane oxygenator].
    Mitsuhata H; Enzan K; Hasegawa J; Matumoto S; Matsumoto J; Kurosawa S
    Masui; 1992 Feb; 41(2):194-9. PubMed ID: 1552659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo effects of C3a on neutrophils and its contribution to inflammatory lung processes in a guinea-pig model.
    Hoffmann T; Böttger EC; Baum HP; Messner M; Hadding U; Bitter-Suermann D
    Clin Exp Immunol; 1988 Mar; 71(3):486-92. PubMed ID: 3260158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit.
    Bochenek A; Religa Z; Kustosz R; Wnuk-Wojnar AM; Wnuk R; Wojnar J; Woś S; Wites M; Zembala M; Spyt T
    Nephrol Dial Transplant; 1991; 6 Suppl 3():75-80. PubMed ID: 1775272
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine and complement levels in patients undergoing cardiopulmonary bypass.
    Steinberg JB; Kapelanski DP; Olson JD; Weiler JM
    J Thorac Cardiovasc Surg; 1993 Dec; 106(6):1008-16. PubMed ID: 8246532
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complement activation during cardiopulmonary bypass: mechanism and prevention].
    Togashi K; Moro H; Nakazawa S; Okazaki H; Yazawa M; Eguchi S
    Kyobu Geka; 1989 Jul; 42(7):529-32. PubMed ID: 2796088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of complement activation during cardiopulmonary bypass. Attenuation by hypothermia, heparin, and hemodilution.
    Moore FD; Warner KG; Assousa S; Valeri CR; Khuri SF
    Ann Surg; 1988 Jul; 208(1):95-103. PubMed ID: 3260474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Improvement of extracorporeal circulation on the basis of anaphylatoxin levels, with special reference to oxygenation mechanisms and plasma denaturation by oxygen bubbling].
    Maeo Y
    Nihon Kyobu Geka Gakkai Zasshi; 1989 Oct; 37(10):2166-74. PubMed ID: 2584778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Different complement and granulocyte activation in patients dialyzed with PMMA dialyzers.
    Hörl WH; Riegel W; Schollmeyer P; Rautenberg W; Neumann S
    Clin Nephrol; 1986 Jun; 25(6):304-7. PubMed ID: 3015463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement split products and the pathogenesis of SLE.
    Abramson SB; Weissmann G
    Hosp Pract (Off Ed); 1988 Dec; 23(12):45-56. PubMed ID: 3142905
    [No Abstract]   [Full Text] [Related]  

  • 38. Anaphylatoxin generation in acute pancreatitis.
    Roxvall L; Bengtson A; Heideman M
    J Surg Res; 1989 Aug; 47(2):138-43. PubMed ID: 2787873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro.
    Videm V; Fosse E; Mollnes TE; Ellingsen O; Pedersen T; Karlsen H
    J Thorac Cardiovasc Surg; 1989 May; 97(5):764-70. PubMed ID: 2709867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complement activation and inflammation].
    Abe M
    Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.